Alar Pharmaceuticals (ROCO:6785) ROE % Adjusted to Book Value : 1.06% (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Alar Pharmaceuticals ROE % Adjusted to Book Value?

Alar Pharmaceuticals's ROE % for the quarter that ended in Dec. 2024 was 4.01%. Alar Pharmaceuticals's PB Ratio for the quarter that ended in Dec. 2024 was 3.79. Alar Pharmaceuticals's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was 1.06%.

Alar Pharmaceuticals ROE % Adjusted to Book Value Historical Data

The historical data trend for Alar Pharmaceuticals's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alar Pharmaceuticals ROE % Adjusted to Book Value Chart

Alar Pharmaceuticals Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-7.75

-2.26

-0.30

4.16

0.28

Alar Pharmaceuticals Quarterly Data
	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial														18.05	0.35	-0.08	-0.50	1.06

Competitive Comparison of Alar Pharmaceuticals's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Alar Pharmaceuticals's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alar Pharmaceuticals's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alar Pharmaceuticals's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Alar Pharmaceuticals's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Alar Pharmaceuticals ROE % Adjusted to Book Value Calculation

Alar Pharmaceuticals's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	1.07%	/	3.79
	=	0.28%

Alar Pharmaceuticals's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	4.01%	/	3.79
	=	1.06%

Alar Pharmaceuticals ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Alar Pharmaceuticals's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Alar Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alar Pharmaceuticals Inc (ROCO:6785) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 32, Keya Road, 5th Floor, Daya District, Taichung, TWN, 407

Website

https://www.alarpharm.com

Alar Pharmaceuticals Inc is a drug development company. It focuses on developing long-acting release drug products for CNS disorders and chronic diseases, which mainly include opioid use disorder, chronic pain, and depressive disorder. These chronic diseases not only cause long-term burdens to the patients and their families but also consume huge social costs.

Alar Pharmaceuticals Headlines

No Headlines